Patents by Inventor Jeremy D. Ollerenshaw

Jeremy D. Ollerenshaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230001202
    Abstract: A system for percutaneously applying electrical stimulation to target nerve tissue to treat a patient having peripheral neuropathy includes a percutaneous electrode assembly, a power supply, and a pulse generator electrically coupled to the percutaneous electrode assembly and the power supply, the pulse generator configured to deliver electrical stimulation to the target nerve tissue via the percutaneous electrode assembly at a level that initiates vasodilation of vasculature within or adjacent the target nerve tissue, where the vasculature is responsible for perfusing the target nerve tissue and the electrical stimulation is delivered with a carrier frequency in the range of 25 kHz to 500 kHz.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Inventors: Jeremy D. Ollerenshaw, Leah M. Roldan, Elliot B. Bourgeois, Eric A. Schepis
  • Patent number: 11471677
    Abstract: Articles and methods for non-invasively treating peripheral neuropathy via transcutaneous electrical stimulation of target nerve tissue are described. An exemplary article includes a support on which an electrode pair is positioned; a controller attached to the electrode pair via one or more leads; and a power supply connected to the controller. The article delivers electrical stimulation to the target nerve tissue via the electrode pair at a level sufficient to initiate vasodilation of vasculature within or adjacent the tissue. Meanwhile, the method includes positioning at least one electrode pair adjacent an area of skin overlying or in close proximity to the target nerve tissue and delivering electrical stimulation to the tissue via the electrode pair. The electrical stimulation is delivered at a level sufficient to initiate vasodilation of vasculature within or adjacent the tissue.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: October 18, 2022
    Assignee: Avent, Inc.
    Inventors: Jeremy D. Ollerenshaw, Leah M. Roldan, Elliot Blake Bourgeois, Eric A. Schepis
  • Patent number: 11464971
    Abstract: A system for selectively blocking nerve fiber activity in a target nerve is provided. The system includes one or more electrodes. The system further includes an electronic control system electrically attached to each electrode to deliver electrical stimulation to a target nerve to block nerve signal transmission of C-fibers in the target nerve such that the nerve signal transmission of A-fibers in the target nerve providing motor function and/or low-threshold sensory function is not blocked. A method of delivering electrical stimulation to selectively block nerve fiber activity in a target nerve and a kit for performing a procedure to selectively block nerve fiber activity are disclosed.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: October 11, 2022
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, Phillip A. Schorr, Jeremy D. Ollerenshaw, Roger D. Massengale, Joshua D. White
  • Publication number: 20200229862
    Abstract: In accordance with one embodiment of the present invention, a method for improving location accuracy of a radiofrequency ablation procedure performed on a patient is contemplated. The method includes identifying a target nerve to be ablated, wherein the nerve is suspected of being a source of pain; delivering a pharmacological agent to the nerve to temporarily block nerve signal transmission along the nerve; verifying the nerve is the source of pain if the temporary block reduces a level of pain experienced by the patient; placing a fiducial marker adjacent the nerve if it is verified that the temporary block reduces the level of pain experienced by the patient; locating the fiducial marker; and delivering radiofrequency energy to an area of tissue adjacent the fiducial marker via a probe. The area of tissue corresponds with the nerve, and the radiofrequency energy is applied at a level sufficient to ablate the nerve.
    Type: Application
    Filed: February 27, 2017
    Publication date: July 23, 2020
    Inventors: Jeremy D. Ollerenshaw, Elliot B. Bourgeois
  • Publication number: 20200023183
    Abstract: Articles and methods for non-invasively treating peripheral neuropathy via transcutaneous electrical stimulation of target nerve tissue are described. An exemplary article includes a support on which an electrode pair is positioned; a controller attached to the electrode pair via one or more leads; and a power supply connected to the controller. The article delivers electrical stimulation to the target nerve tissue via the electrode pair at a level sufficient to initiate vasodilation of vasculature within or adjacent the tissue. Meanwhile, the method includes positioning at least one electrode pair adjacent an area of skin overlying or in close proximity to the target nerve tissue and delivering electrical stimulation to the tissue via the electrode pair. The electrical stimulation is delivered at a level sufficient to initiate vasodilation of vasculature within or adjacent the tissue.
    Type: Application
    Filed: December 8, 2017
    Publication date: January 23, 2020
    Inventors: Jeremy D. Ollerenshaw, Leah M. Roldan, Elliot B. Bourgeois, Eric A. Schepis
  • Publication number: 20170224989
    Abstract: A system for selectively blocking nerve fiber activity in a target nerve is provided. The system includes one or more electrodes. The system further includes an electronic control system electrically attached to each electrode to deliver electrical stimulation to a target nerve to block nerve signal transmission of C-fibers in the target nerve such that the nerve signal transmission of A-fibers in the target nerve providing motor function and/or low-threshold sensory function is not blocked. A method of delivering electrical stimulation to selectively block nerve fiber activity in a target nerve and a kit for performing a procedure to selectively block nerve fiber activity are disclosed.
    Type: Application
    Filed: August 24, 2015
    Publication date: August 10, 2017
    Inventors: Eric A. Schepis, Phillip A. Schorr, Jeremy D. Ollerenshaw, Roger Massengale, Joshua D. White
  • Publication number: 20100285587
    Abstract: A method of preparing a tissue graft material is disclosed. The disclosure also relates to a multipurpose tissue graft material and to methods of using same as a replacement for vascular and non-vascular tissue.
    Type: Application
    Filed: July 23, 2010
    Publication date: November 11, 2010
    Applicant: CRYOLIFE, INC.
    Inventors: Jeremy D. Ollerenshaw, Steven Goldstein, Kirby S. Black
  • Patent number: 7763081
    Abstract: The present invention relates to a method of preparing a tissue graft material. The invention also relates to a multipurpose tissue graft material and to methods of using same as a replacement for vascular and non-vascular tissue.
    Type: Grant
    Filed: February 3, 2005
    Date of Patent: July 27, 2010
    Assignee: Cryolife, Inc.
    Inventors: Jeremy D. Ollerenshaw, Steven Goldstein, Kirby S. Black
  • Patent number: 6866686
    Abstract: The present invention relates to a method of preparing a tissue graft material. The invention also relates to a multipurpose tissue graft material and to methods of using same as a replacement for vascular and non-vascular tissue.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: March 15, 2005
    Assignee: Cryolife, Inc.
    Inventors: Jeremy D. Ollerenshaw, Steven Goldstein, Kirby S. Black
  • Publication number: 20020128724
    Abstract: The present invention relates to a method of preparing a tissue graft material. The invention also relates to a multipurpose tissue graft material and to methods of using same as a replacement for vascular and non-vascular tissue.
    Type: Application
    Filed: January 26, 2001
    Publication date: September 12, 2002
    Inventors: Jeremy D. Ollerenshaw, Steven Goldstein, Kirby S. Black